Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Roivant Sciences (ROIV) Tax Provisions (2020 - 2025)

Roivant Sciences (ROIV) has disclosed Tax Provisions for 6 consecutive years, with $23.3 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Tax Provisions rose 191.25% year-over-year to $23.3 million, compared with a TTM value of $9.4 million through Dec 2025, down 55.66%, and an annual FY2025 reading of $48.2 million, up 124.03% over the prior year.
  • Tax Provisions was $23.3 million for Q4 2025 at Roivant Sciences, up from $7.0 million in the prior quarter.
  • Across five years, Tax Provisions topped out at $23.3 million in Q4 2025 and bottomed at -$25.6 million in Q4 2024.
  • Average Tax Provisions over 5 years is $5.0 million, with a median of $3.6 million recorded in 2022.
  • The sharpest move saw Tax Provisions skyrocketed 7318.42% in 2022, then plummeted 214.32% in 2024.
  • Year by year, Tax Provisions stood at $38000.0 in 2021, then surged by 7318.42% to $2.8 million in 2022, then skyrocketed by 693.37% to $22.4 million in 2023, then tumbled by 214.32% to -$25.6 million in 2024, then soared by 191.25% to $23.3 million in 2025.
  • Business Quant data shows Tax Provisions for ROIV at $23.3 million in Q4 2025, $7.0 million in Q3 2025, and $4.6 million in Q2 2025.